Phase 3 Open-Label Study Evaluating the Efficacy and Safety of Mavacamten in Japanese Adults With Obstructive Hypertrophic Cardiomyopathy ― The HORIZON-HCM Study ―Hiroaki Kitaoka, Chisato Izumi, Morimasa Takayama et al.|Circulation Journal|2024Cited by 23
Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its roleHironori Yamamoto, Yasushi Sakata, Yohei Miyashita et al.|Scientific Reports|2023Cited by 4